5% imiquimod suppositories decrease the DNA load of intra-anal HPV types 6 and 11 in HIV-infected men after surgical ablation of condylomata acuminata.
Alexander
A
Kreuter
Norbert H
NH
Brockmeyer
Soenke J
SJ
Weissenborn
Arasch
A
Wafaisade
Herbert
H
Pfister
Peter
P
Altmeyer
Ulrike
U
Wieland
D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000328:Adult; D000634:Aminoquinolines / Q000008:administration & dosage*; D003218:Condylomata Acuminata / Q000150:complications / Q000188:drug therapy / Q000601:surgery*; D004279:DNA, Viral / Q000187:drug effects* / Q000235:genetics; D004305:Dose-Response Relationship, Drug; D004564:Electrocoagulation; D005500:Follow-Up Studies; D015658:HIV Infections / Q000150:complications*; D052140:Human papillomavirus 11 / Q000187:drug effects / Q000235:genetics*; D052163:Human papillomavirus 6 / Q000187:drug effects / Q000235:genetics*; D006801:Humans; D000077271:Imiquimod; D008297:Male; D012002:Rectal Diseases / Q000150:complications / Q000188:drug therapy / Q000601:surgery*; D013488:Suppositories; D016896:Treatment Outcome; D019562:Viral Load
D000276:Adjuvants, Immunologic; D000634:Aminoquinolines; D004279:DNA, Viral; D013488:Suppositories; D000077271:Imiquimod